CD14 and Hypoglycemia: Given that hypoglycemia, assessed by CGM, is associated with atherosclerosis in non-DM patients [40], hypoglycemia and associated glucose fluctuations could explain the significant correlation that was observed in the non-DM patients between the MAGE scores and CD14++CD16+ monocyte levels.